prednisolone- Prednisolone tablet

Riik: Ameerika Ühendriigid

keel: inglise

Allikas: NLM (National Library of Medicine)

Toimeaine:

Prednisolone (UNII: 9PHQ9Y1OLM) (Prednisolone - UNII:9PHQ9Y1OLM)

Saadav alates:

Watson Laboratories, Inc.

INN (Rahvusvaheline Nimetus):

Prednisolone

Ravimvorm:

TABLET

Koostis:

5 mg

Manustamisviis:

ORAL

Retsepti tüüp:

PRESCRIPTION DRUG

Näidustused:

1. Endocrine disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic disorders. As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis; including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) Ankylosing spondylitis Acute and subacute bursitis Acute nonspecific tenosynovitis Acute gouty arthritis Post-traumatic osteoarthritis Synovitis of osteoarthritis Epicondylitis 3. Collagen diseases. During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus Acute rheumatic carditis Systemic dermatomyositis (polymyosit

Toote kokkuvõte:

Prednisolone Tablets USP 5 mg are scored, round, peach tablets imprinted DAN DAN 5059 supplied in bottles of 100, and 1000. Dispense in a well-closed container with child-resistant closure. Store at 20°-25°C (68°-77°F). [See USP controlled room temperature.] Watson Laboratories, Inc. Corona, CA 92880 USA Revised: June 2006

Toote omadused

PREDNISOLONE- PREDNISOLONE TABLET
WATSON LABORATORIES, INC.
----------
FPO
PREDNIS OLONE
TABLETS USP
REVISED: JUNE 2006
RX ONLY
DESCRIPTION
Glucocorticoids are adrenocortical steroids, both naturally occurring
and synthetic, which are readily
absorbed from the gastrointestinal tract. Prednisolone is a white
crystalline powder, very slightly
soluble in water. It is designated chemically as
pregna-1,4-diene-3,20-dione,11,17,21-trihydroxy-
,(11ß)-. The structural formula is represented below:
C H O
M.W. 360.4 5
Prednisolone Tablets USP 5 mg contain the following inactive
ingredients: anhydrous lactose, colloidal
silicon dioxide, crospovidone, D&C Yellow No.10, docusate sodium, FD&C
Yellow No. 6,
magnesium stearate and sodium benzoate.
CLINICAL PHARMACOLOGY
Naturally occurring glucocorticoids (hydrocortisone and cortisone),
which also have salt-retaining
properties, are used as replacement therapy in adrenocortical
deficiency states. Prednisolone is
primarily used for its potent anti-inflammatory effects in disorders
of many organ systems.
Glucocorticoids cause profound and varied metabolic effects. In
addition, they modify the body's
immune responses to diverse stimuli.
INDICATIONS AND USAGE
1. ENDOCRINE DISORDERS. Primary or secondary adrenocortical
insufficiency (hydrocortisone or
cortisone is the first choice; synthetic analogs may be used in
conjunction with mineralocorticoids
where applicable; in infancy mineralocorticoid supplementation is of
particular importance).
Congenital adrenal hyperplasia
Nonsuppurative thyroiditis
Hypercalcemia associated with cancer
21
28
5
2. RHEUMATIC DISORDERS. As adjunctive therapy for short-term
administration (to tide the patient over an
acute episode or exacerbation) in:
Psoriatic arthritis
Rheumatoid arthritis; including juvenile rheumatoid arthritis
(selected cases may require low-dose
maintenance therapy)
Ankylosing spondylitis
Acute and subacute bursitis
Acute nonspecific tenosynovitis
Acute gouty arthritis
Post-traumatic osteoarthritis
Synovitis of osteoarthritis
Epicond